RYTTX
Price
$260.14
Change
+$8.93 (+3.55%)
Updated
Apr 11 closing price
Net Assets
153.8M
RYVYX
Price
$414.08
Change
+$14.65 (+3.67%)
Updated
Apr 11 closing price
Net Assets
635.42M
Ad is loading...

RYTTX vs RYVYX

Header iconRYTTX vs RYVYX Comparison
Open Charts RYTTX vs RYVYXBanner chart's image
Rydex S&P 500 2x Strategy A
Price$260.14
Change+$8.93 (+3.55%)
VolumeN/A
Net Assets153.8M
Rydex NASDAQ-100® 2x Strategy H
Price$414.08
Change+$14.65 (+3.67%)
VolumeN/A
Net Assets635.42M
RYTTX vs RYVYX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RYTTX vs. RYVYX commentary
Apr 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RYTTX is a Buy and RYVYX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RYVYX has more cash in the bank: 635M vs. RYTTX (154M). RYTTX pays higher dividends than RYVYX: RYTTX (0.39) vs RYVYX (0.00). RYTTX was incepted earlier than RYVYX: RYTTX (21 years) vs RYVYX (25 years). RYVYX (2.00) and RYTTX (1.94) have similar cost to investors . RYTTX is a more actively managed with annual turnover of: 1312.00 vs. RYVYX (392.00). RYTTX (2500) and RYVYX (2500) have matching initial minimum investment requirements. RYTTX annual gain was more profitable for investors over the last year : -6.74 vs. RYVYX (-12.35). RYVYX (165.37) and RYTTX (161.33) have equivalent 5 years return.
RYTTXRYVYXRYTTX / RYVYX
Total Expense Ratio1.861.8998%
Annual Report Gross Expense Ratio1.942.0097%
Fund Existence21 years25 years-
Gain YTD-19.764-24.76580%
Front Load5%N/A-
Min. Initial Investment25002500100%
Min. Initial Investment IRAN/AN/A-
Net Assets154M635M24%
Annual Yield % from dividends0.390.00-
Returns for 1 year-6.74-12.3555%
Returns for 3 years13.8221.8163%
Returns for 5 years161.33165.3798%
Returns for 10 years262.52444.7359%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ATNF0.850.16
+22.95%
180 Life Sciences Corp
KALV11.490.95
+9.01%
KalVista Pharmaceuticals
ACAD14.580.47
+3.33%
ACADIA Pharmaceuticals
FMS23.980.16
+0.67%
Fresenius Medical Care AG
FNGR1.30-0.06
-4.41%
FingerMotion